Tables
- TABLE 1
Outcomes following cough control therapy (CCT) for patients with chronic refractory cough (CRC) and explained cough
Aetiology LCQ LHQ Patients with pre- and post-CCT scores Pre-CCT Post-CCT Change Patients with pre- and post-CCT scores Pre-CCT Post-CCT Change CRC (n=228) 145 12.4±3.4 17.0±3.3 4.55±3.4 115 14.4±2.8 17.3±2.8 2.87±2.6 Explained cough (n=98) 57 11.6±3.6 15.4±4.3 3.76±5.1 51 14.6±3.0 16.9±3.2 2.34±3.0 Asthma (n=58) 36 11.3±3.3 15.6±4.4 4.27±4.8 33 14.6±3.2 16.9±3.6 2.24±3.2 COPD (n=12) 5 10.3±3.3 14.8±5.5 4.5±5.6 2 14.3±4.5 18.5±3.1 4.17±1.4 ILD (n=7) 3 12.7±2.2 16.2±3.4 3.51±4.1 3 14.8±2.7 18.2±1.7 3.33±2.0 Bronchiectasis (n=16) 9 12.1±4.8 14.5±4.5 2.41±6.8 11 14.1±2.7 16.3±2.7 2.14±3.5 Xerotrachea (n=5) 4 13.7±5.6 15.2±3.3 1.50±4.4 2 15.5±1.7 17.3±1.8 1.81±0.2 Data are presented as mean±sd unless otherwise stated. LCQ: Leicester Cough Questionnaire; LHQ: Laryngeal Hypersensitivity Questionnaire; ILD: interstitial lung disease.
Vol 6 Issue 1
Table of Contents
Nonpharmacological cough control therapy for chronic refractory cough and cough associated with underlying lung disease
